TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
VKTX

Viking Therapeutics Inc

Healthcare · Biotechnology

28.50$ +0.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement VKTX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – 100.0% 100.0% – – – –
– – – – – – 2,581.3% 2,766.1% – – – –
– – – – – – 100.0% -2,766.1% – – – –
– – – – – – 297,558.5% 420,343.9% – – – –
– – – – – – 100,000.0% 100,000.0% – – – –
– – – – – – 397,558.5% 520,343.9% – – – –
– – – – – – -397,558.5% -520,343.9% – – – –
– – – – – – 987.8% 168.2% – – – –
– – – – – – -368,045.8% -513,877.2% – – – –
– – – – – – -32,466.7% -9,232.8% – – – –
– – – – – – -368,045.8% -513,877.2% – – – –
– – – – – – 35,117.9% -510,942.9% – – – –

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?